Trial Profile
A Study to Evaluate the Risk for Hospitalized Heart Failure (hHF) Among Type 2 Diabetes Mellitus (T2DM) Patients Treated With Saxagliptin, Sitagliptin and Other Antihyperglycemic Drugs
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 04 May 2016
Price :
$35
*
At a glance
- Drugs Saxagliptin (Primary) ; Sitagliptin (Primary) ; Insulin; Pioglitazone; Sulfonylureas
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions
- 04 May 2016 New trial record
- 26 Apr 2016 Results published in the Annals of Internal Medicine